Skip to search formSkip to main contentSkip to account menu

Warfarin

Known as: 3-Alpha-phenyl-beta-acetylethyl-4-hydroxycoumarin, 3-(.alpha.-Phenyl-.beta.-acetylethyl)-4-hydroxycoumarin, 2H-1-Benzopyran-2-one, 4-hydroxy-3-(3-oxo-1-phenylbutyl)- 
A synthetic anticoagulant. Warfarin inhibits the regeneration of vitamin K1 epoxide and so the synthesis of vitamin K dependent clotting factors… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
The effect of simvastatin co-medication on warfarin anticoagulation response and dose requirements - 
1989
1989
Excerpt The recent letter by Linville and Matanin (1) brought attention to an interaction between norfloxacin (Noroxin, Merck… 
Highly Cited
1984
Highly Cited
1984
A stereospecific assay for the simultaneous determination of the enantiomers of warfarin and its major metabolites, 6- and 7… 
1984
1984
Erythromycin is generally regarded as innocuous in regard to adverse interactions with other drugs. Recently, however, its… 
1984
1984
A 35-year-old woman was receiving warfarin sodium therapy for a prosthetic aortic valve. She sustained a myocardial infarction… 
1978
1978
SUMMARY Baiting with medium oatmeal or soaked wheat containing 0.002, 0.001 or 0.0005% brodifacoum completely controlled… 
1974
1974
The biological half-life of warfarin in a group of male Sprague–Dawley rats varied from 5 to 28 hr, and the apparent volume of… 
1970
1970
Abstract The recognition of drugs that interact with warfarin has clinical relevance because of potential serious reactions as a… 
1964
1964
A method of coating aspirin crystals of various mesh sizes with mixtures of ethylcellulose and methylcellulose using the WARF…